Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Convertible Preferred Stock and Shareholders??? Equity (Deficit)

v3.22.1
Consolidated Statements of Convertible Preferred Stock and Shareholders’ Equity (Deficit) - USD ($)
$ in Thousands
Convertible Preferred Stock
Special Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance (in Shares) at Dec. 31, 2018 50,588,630 1 3,867,136        
Beginning balance at Dec. 31, 2018 $ 35,691 $ 4 $ 996 $ (21,735) $ (20,735)
Retroactive application of Exchange Ratio (in Shares) 51,260,712 1 3,918,511        
Retroactive application of Exchange Ratio $ (3) 3
Ending balance (in Shares) at Dec. 31, 2019 101,849,342 2 7,785,647        
Ending balance at Dec. 31, 2019 $ 35,691 $ 1 999 (21,735) (20,735)
Net loss (7,437) (7,437)
Issuance of preferred shares, net of issuance costs of $20.0 thousand (in Shares) 16,037,640            
Issuance of preferred shares, net of issuance costs of $20.0 thousand $ 10,241
Special Stock conversion    
Special Stock conversion (in Shares)   (2) 2        
Share-based compensation 278 278
Shares issued for stock options exercised 32 32
Shares issued for stock options exercised (in Shares)     375,179        
Ending balance (in Shares) at Dec. 31, 2020 117,886,982   8,160,828        
Ending balance at Dec. 31, 2020 $ 45,932 $ 1 1,309 (29,172) (27,862)
Net loss (137,408) (137,408)
Other comprehensive loss (4) (4)
Share-based compensation 11,380 11,380
Shares issued for stock options exercised 462 462
Shares issued for stock options exercised (in Shares)     4,756,937        
Shares issued for stock warrants exercised 30 30
Shares issued for stock warrants exercised (in Shares)     199,315        
Conversion of preferred stock to common stock (in Shares) (117,886,982)   121,038,967        
Conversion of preferred stock to common stock $ (45,932) $ 12 45,920 45,932
Conversion of stock warrants to common stock 3,011 3,011
Conversion of stock warrants to common stock (in Shares)     582,509        
Conversion of SAFE instruments to common stock $ 2 170,316 170,318
Conversion of SAFE instruments to common stock (in Shares)     20,080,464        
Reverse recapitalization and PIPE financing, net $ 3 148,196 148,199
Reverse recapitalization and PIPE financing, net (in Shares)     28,548,017        
Ending balance (in Shares) at Dec. 31, 2021     183,367,037        
Ending balance at Dec. 31, 2021 $ 18 $ 380,624 $ (4) $ (166,580) $ 214,058